Anti-ADAMTS13 Autoantibodies: From Pathophysiology to Prognostic Impact—A Review for Clinicians

Anti-ADAMTS13 Autoantibodies: From Pathophysiology to Prognostic Impact—A Review for Clinicians

Thrombotic thrombocytopenic purpura (TTP) is a fatal disease in which platelet-rich microthrombi cause end-organ ischemia and damage. TTP is caused by markedly reduced ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) activity. ADAMTS13 autoantibodies (auto...

Full description

Bibliographic Details
Main Authors:	Cristina Dainese, Federica Valeri, Benedetto Bruno, Alessandra Borchiellini
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Series:	Journal of Clinical Medicine
Subjects:	thrombotic thrombocytopenic purpura Moskowitz syndrome ADAMTS13 autoantibodies ADAMTS13 inhibitors
Online Access:	https://www.mdpi.com/2077-0383/12/17/5630

Similar Items

Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
by: Mari R. Thomas, et al.
Published: (2015-08-01)

Inherited ADAMTS13 mutations associated with Thrombotic Thrombocytopenic Purpura: a short review and update
by: Zoe Markham-Lee, et al.
Published: (2023-01-01)

ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura
by: Quintijn Bonnez, et al.
Published: (2023-09-01)

Post-cardiac surgery thrombotic thrombocytopenic purpura: presence of anti-ADAMTS13 autoantibodies at preoperative baseline
by: Bryan Tordon, et al.
Published: (2022-04-01)

A chronic recurrent course of moschcowitz disease
by: I I Kalinina, et al.
Published: (2008-07-01)

Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice
by: K. N. Grigoreva, et al.
Published: (2021-03-01)

Hereditary Thrombotic Thrombocytopenic Purpura
by: Sanober Nusrat, et al.
Published: (2023-10-01)

Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS‐13 activity and autoantibodies
by: Francesca Palandri, et al.
Published: (2021-12-01)

ADAMTS13 levels in a plasma-derived FVIII concentrate: A potential therapeutic option for patients with congenital thrombotic thrombocytopenic purpura
by: Filippo Mori, et al.
Published: (2022-12-01)

Concentration and Subclass Distribution of Anti-ADAMTS13 IgG Autoantibodies in Different Stages of Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
by: György Sinkovits, et al.
Published: (2018-07-01)

Generation and validation of small ADAMTS13 fragments for epitope mapping of anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura
by: Kadri Kangro, et al.
Published: (2020-07-01)

Incidence of thrombotic microangiopathies in Quebec: insight from a laboratory centralizing ADAMTS-13 testing
by: Clémence Merlen, et al.
Published: (2022-08-01)

Congenital Thrombotic Thrombocytopenic Purpura: Atypical Presentation And First ADAMTS 13 Mutation In A Tunisian Child
by: aida borgi
Published: (2013-06-01)

Idiopathic Relapsing Thrombotic Thrombocytopenic Purpura with Persistent ADAMTS13 Inhibitor Activity Treated Sequentially with Plasmapheresis, Rituximab, Cyclophosphamide and Splenectomy
by: Faisal Musa, et al.
Published: (2015-04-01)

Diagnostic relevance of ADAMTS13 activity: Evaluation of 28 patients with thrombotic thrombocytopenic purpura - hemolytic uremic syndrome clinical diagnosis
by: Vučelić Dragica, et al.
Published: (2013-01-01)

Anti-ADAMTS13 Antibodies and a Novel Heterozygous p.R1177Q Mutation in a Case of Pregnancy-Onset Immune-Mediated Thrombotic Thrombocytopenic Purpura
by: Elien Roose, et al.
Published: (2018-01-01)

A rare case of hereditary thrombotic thrombocytopenic purpura in a toddler
by: Ozana Jakšić, et al.
Published: (2023-01-01)

Recurrent stroke in an African female with idiopathic thrombotic thrombocytopenic purpura: A case report
by: Kwabena Oteng Agyapong, et al.
Published: (2023-01-01)

COVID-19 infection triggering Thrombotic Thrombocytopenic Purpura
by: Mohammad Alhomoud, et al.
Published: (2021-01-01)

An ADAMTS13 mutation that causes hereditary thrombotic thrombocytopenic purpura: a case report and literature review
by: Pengzhu Li, et al.
Published: (2021-10-01)

Two novel mutations in ADAMTS13 in a Chinese boy with congenital thrombocytopenic purpura: a case report
by: Ling Hou, et al.
Published: (2020-03-01)

The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer
by: Chanukya K. Colonne, et al.
Published: (2022-03-01)

Economic impact of a rapid, on‐demand ADAMTS‐13 activity assay for the diagnosis of thrombotic thrombocytopenic purpura
by: Alicia White, et al.
Published: (2022-05-01)

Diagnosis and follow‐up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay
by: Nicolas Beranger, et al.
Published: (2021-01-01)

Bethesda Assay for Detecting Inhibitory Anti-ADAMTS13 Antibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura
by: Chiara Vendramin, et al.
Published: (2018-07-01)

The Progress in Research in Hereditary Thrombotic Thrombocytopenic Purpura in Children
by: FU Lingling, et al.
Published: (2022-10-01)

Focus on Key Issues in Immune Thrombotic Thrombocytopenic Purpura: Italian Experience of Six Centers
by: Giovanni Tiscia, et al.
Published: (2021-12-01)

Outcome of Thrombotic Thrombocytopenic Purpura Patients: A Single-Center Experience
by: Özcan Çeneli, et al.
Published: (2019-08-01)

Flavorubredoxin, a Candidate Trigger Related to Thrombotic Thrombocytopenic Purpura: Screening of the Complete Genome of a Salmonella enterica Serovar Typhimurium Isolate From an AIDS Case
by: Zhouhan Wang, et al.
Published: (2022-06-01)

Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management
by: Senthil Sukumar, et al.
Published: (2021-02-01)

Acquired thrombotic thrombocytopenia purpura associated with severe ADAMTS13 deficiency in a 3-year-old boy: a case report and review of the literature
by: Hamidah Alias, et al.
Published: (2018-09-01)

Residues R1075, D1090, R1095, and C1130 Are Critical in ADAMTS13 TSP8-Spacer Interaction Predicted by Molecular Dynamics Simulation
by: Zhiwei Wu, et al.
Published: (2021-12-01)

Diagnosis of thrombotic thrombocytopenic purpura
by: G. M. Galstyan, et al.
Published: (2020-12-01)

Immune thrombotic thrombocytopenic purpura: Spotlight on long-term outcomes and survivorship
by: Sruthi Selvakumar, et al.
Published: (2023-02-01)

A Long-Term Follow-Up Study in Immune-Mediated Thrombotic Thrombocytopenic Purpura: What Are the Outcomes?
by: Maria Addolorata Bonifacio, et al.
Published: (2023-11-01)

Autoimmune thrombotic thrombocytopenic purpura associated with disseminated sarcoidosis: A case report
by: Maxime Billotte, et al.
Published: (2024-02-01)

Global Health Resource Utilization and Cost-Effectiveness of Therapeutics and Diagnostics in Immune Thrombotic Thrombocytopenic Purpura (TTP)
by: Ayesha Butt, et al.
Published: (2023-07-01)

Prolonged Exposure to Caplacizumab as Rescue Therapy in Refractory Immune Thrombotic Thrombocytopenic Purpura
by: Rodgers GM, et al.
Published: (2023-03-01)

Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura - a case report and concise review of the literature
by: D Brodmann
Published: (2007-09-01)

Chest pain with increased troponin level; not always a cardiology issue
by: Papadatos Stamatis S., et al.
Published: (2019-06-01)